Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study

Author(s)

da Silva, Isis T. ^[1] ; Timm, Anelise de Souza ^[1] ; Damasceno, Nagila R. T. ^{[1, 2]}

Affiliation

^[1] Univ Sao Paulo, Sch Publ Hlth, Dept Nutr, Sao Paulo - Brazil

^[2] Fac Saude Publ, Dept Nutr, BR-01246904 Sao Paulo - Brazil

• Document type: Journal article
• Source: LIPIDS IN HEALTH AND DISEASE; v. 12, FEB 15 2013.
• Web of Science Citations: 14

Abstract

Background: Lipoprotein-associated phospholipase A(2) activity (Lp-PLA(2)) is a good marker of cardiovascular risk in adults. It is strongly associated with stroke and many others cardiovascular events. Despite this, the impact of obesity on this enzyme activity and its relation to biomarkers of cardiovascular disease in adolescents is not very well investigated. The purpose of this article is to evaluate the influence of obesity and cardiometabolic markers on Lp-PLA(2) activity in adolescents. Results: This cross-sectional study included 242 adolescents (10-19 years) of both gender. These subjects were classified in Healthy Weight (n = 77), Overweight (n = 82) and Obese (n = 83) groups. Lipid profile, glucose, insulin, HDL size, LDL(-) and anti-LDL(-) antibodies were analyzed. The Lp-PLA(2) activity was determined by a colorimetric commercial kit. Body mass index (BMI), waist circumference and body composition were monitored. Food intake was evaluated using three 24-hour diet recalls. The Lp-PLA(2) activity changed in function to high BMI, waist circumference and fat mass percentage. It was also positively associated with HOMA-IR, glucose, insulin and almost all variables of lipid profile. Furthermore, it was negatively related to Apo AI (beta = -0.137; P = 0.038) and strongly positively associated with Apo B (beta = 0.293; P < 0.001) and with Apo B/Apo AI ratio (beta = 0.343; P < 0.001). The better predictor model for enzyme activity, on multivariate analysis, included Apo B/Apo AI (beta = 0.327; P < 0.001), HDL size (beta = -0.326; P < 0.001), WC (beta = 0.171; P = 0.006) and glucose (beta = 0.119; P = 0.038). Logistic regression analysis demonstrated that changes in Apo B/Apo AI ratio were associated with a 73.5 times higher risk to elevated Lp-PLA(2) activity. Conclusions: Lp-PLA(2) changes in function of obesity, and that it shows important associations with markers of cardiovascular risk, in particular with waist circumference, glucose, HDL size and Apo B/Apo AI ratio. These results suggest that Lp-PLA(2) activity can be a cardiovascular biomarker in adolescence. (AU)